MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-04-2026
QIAGEN N.V. Total Inventories 2011-2026 | QGEN
Annual Total Inventories QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 302 M | 279 M | 398 M | 358 M | 328 M | 291 M | 171 M | 163 M | 156 M | 137 M | 137 M | 132 M | 128 M | 135 M | 132 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 398 M | 128 M | 216 M |
Quarterly Total Inventories QIAGEN N.V.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 328 M | - | - | - | 291 M | - | - | - | 171 M | - | - | - | 163 M | - | - | - | 156 M | - | - | - | 137 M | - | - | - | 137 M | - | - | - | 132 M | - | - | - | 128 M | - | - | - | 135 M | - | - | - | 132 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 328 M | 128 M | 174 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
830 M | $ 113.25 | -1.38 % | $ 34.4 B |  USA |
 |
CareDx, Inc
CDNA
|
26.7 M | $ 17.42 | -2.24 % | $ 928 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
123 M | $ 16.35 | 0.28 % | $ 172 M |  China |
 |
Co-Diagnostics
CODX
|
992 K | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Danaher Corporation
DHR
|
2.49 B | $ 189.05 | -1.58 % | $ 135 B | USA |
 |
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | USA |
 |
DexCom
DXCM
|
629 M | $ 63.32 | 0.17 % | $ 24.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | China |
 |
Charles River Laboratories International
CRL
|
299 M | $ 166.89 | -0.79 % | $ 8.27 B | USA |
 |
Castle Biosciences
CSTL
|
8.14 M | $ 24.75 | 0.08 % | $ 687 M | USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
85.9 M | $ 90.17 | 0.56 % | $ 11.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 107.87 | -1.6 % | $ 8.9 B |  Irlanda |
 |
Illumina
ILMN
|
547 M | $ 126.04 | -1.33 % | $ 20 B | USA |
 |
Biomerica
BMRA
|
1.49 M | $ 2.13 | -1.84 % | $ 4.89 M | USA |
 |
BioNano Genomics
BNGO
|
7.83 M | $ 1.15 | -0.43 % | $ 6.26 M | USA |
 |
Interpace Biosciences
IDXG
|
1.11 M | $ 1.98 | 0.51 % | $ 8.76 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
535 M | $ 271.93 | -0.96 % | $ 22.6 B | USA |
 |
Lantheus Holdings
LNTH
|
64.7 M | $ 76.19 | 0.4 % | $ 5.14 B | USA |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | USA |
 |
Myriad Genetics
MYGN
|
30.6 M | $ 4.64 | -0.54 % | $ 430 M | USA |
 |
NeoGenomics
NEO
|
28.6 M | $ 7.9 | -1.5 % | $ 1.01 B | USA |
 |
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | USA |
 |
Neogen Corporation
NEOG
|
191 M | $ 9.93 | 3.82 % | $ 2.15 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
189 M | $ 198.9 | -0.08 % | $ 22.1 B | USA |
 |
Natera
NTRA
|
35.4 M | $ 206.47 | 0.78 % | $ 20.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
2.62 M | $ 4.71 | -0.74 % | $ 3.71 M | USA |
 |
Pacific Biosciences of California
PACB
|
49.3 M | $ 1.42 | - | $ 426 M | USA |
 |
Precipio
PRPO
|
935 K | $ 26.03 | 0.19 % | $ 41.8 M | USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |